期刊文献+

葡萄糖神经酰胺合成酶siRNA表达载体的构建 被引量:1

Construction of glucosylceramide synthase siRNA expression vectors
下载PDF
导出
摘要 目的构建针对葡萄糖神经酰胺合成酶(GCS)mRNA的siRNA表达载体,并观察其对转染细胞中GCS表达的影响。方法根据人GCSmRNA编码序列,设计并合成3对针对GCS的发卡状RNA的寡核苷酸,各64个碱基,退火后插入pSUPEREGFP载体重组构建RNAi质粒,进行双酶切及测序鉴定。重组质粒用脂质体包裹转染入SGC7901/VCR细胞,采用RT-PCR检测GCSmRNA表达水平的变化。结果重组构建的载体经酶切鉴定与测序分析,显示特定位点靶序列与设计序列完全一致。转染SGC7901/VCR细胞后,GCSmRNA表达明显降低。结论GCSsiRNA表达载体构建成功,并可有效抑制人胃癌耐药SGC7901/VCR细胞中GCS的表达,为后续研究及肿瘤的基因治疗奠定了基础。 Aim: To construct glueosyleeramide synthase(GCS) siRNA expression vectors and to observe their effect on GCS mRNA expression in transfeeted cells. Methods:According to the encoding sequence of mRNA of human GCS, three pairs of GCS specific target gene sequence were designed and synthesized. The annealed oligonueleotide fragments were inserted into the pSUPER EGFP vector. After being identified by double digestion with the enzymes and DNA sequencing, the recombinants were transfected into SGC7901/VCR cells using Lipofectamine^TM 2000. The expression of GCS mRNA was detected by RT-PCR. Results: Recombinant plasmids were identified by digestion with EcoR Ⅰ and Hind Ⅲ ,and confirmed by sequencing analysis. The results demonstrated that the insertion sequence was exactly correct. GCS mRNA expression significantly reduced after transfeetion. Conclusion: The expression vector of GCS siRNA has been constructed successfully and can suppress the GCS mRNA expression in gastric carcinoma cells, which lays a basis for further studies of GCS function and its application in the gene treatment of tumors.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第3期467-470,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省重大科技攻关基金资助项目0222031300
关键词 葡萄糖神经酰胺合成酶 SIRNA 表达载体 胃肿瘤 glucosylceramide synthase siRNA expression vector gastric neoplasm
  • 相关文献

参考文献12

  • 1项柏康.胃癌多药耐药基因研究的现状[J].浙江临床医学,2006,8(8):785-785. 被引量:1
  • 2张艳,刘宗文,贾丹辉,乐晓萍,张钦宪.葡萄糖神经酰胺合成酶基因在人胃癌细胞SGC-7901及SGC-7901/VCR的表达和意义[J].世界华人消化杂志,2007,15(9):1008-1011. 被引量:6
  • 3Tuschl T.Expanding small RNA inteference[J].Nat Biotechnol,2002,20 (5):446
  • 4Volm M.Multidrug resistance and its reversal[J].Anticancer Res,1998,18 (4C):2 905
  • 5Kohyama-Koganeya A,SasamuraT,Oshima E,et al.Drosophila glucosylceramide synthase:a negative regulator of cell death mediated by proapoptotic factors[J].J Biol Chem,2004,279(34):35 995
  • 6Reynolds CP,Maurer BJ,Kolesnick RN.Ceramide synthesis and metabolism as a target for cancer therapy[J].Cancer lett,2004,206 (2):169
  • 7Shabbits JA,Mayer LD.P-glycoprotein modulates ceramidemediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs[J].Mol Cancer Ther,2002,1 (3):205
  • 8Lucci A,Han TY,Liu YY,et al.Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells[J].Cancer,1999,86 (2):300
  • 9Funato T.Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug ersistance[J].Method Mol Med,2005,106:215
  • 10Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cell[J].Nature,2001,411 (6 836):494

二级参考文献17

  • 1李江涛,彭淑牖,刘颖斌,王新保,王海军,王建伟,许斌,李海军,冯雪冬,钱浩然,吴育连,方河清.糖基化神经酰胺合成酶及相关基因的表达与人胆囊癌多药耐药[J].中华普通外科杂志,2005,20(6):382-383. 被引量:9
  • 2孙妍琳,周庚寅,李锴男,林晓燕,高鹏,郭成浩,侯丽.人乳腺癌细胞中葡萄糖神经酰胺合成酶基因的表达和意义[J].中国现代普通外科进展,2005,8(3):141-143. 被引量:3
  • 3马荣,陈曦海,张岂凡,唐丽萍.反义Survivin核酸诱导凋亡及逆转胃癌耐药机制的实验研究[J].世界华人消化杂志,2006,14(12):1139-1145. 被引量:2
  • 4Lavie Y,Cao H,Bursten SL,Giuliano AE,Cabot MC.Accumulation of glucosylceramides in multidrug-resistant cancer cells.J Biol Chem 1996;271:19530-19536
  • 5Gouaze V,Yu JY,Bleicher RJ,Han TY,Liu YY,Wang H,Gottesman MM,Bitterman A,Giuliano AE,Cabot MC.Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.Mol Cancer Ther 2004; 3:633-639
  • 6Weiss M,Hettmer S,Smith P,Ladisch S.Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase.Cancer Res 2003; 63:3654-3658
  • 7J.萨母布鲁克,D.W.拉赛尔.分子克隆实验指南.第3版.北京:科学出版社,2003:522-525
  • 8Wu XX,Kakehi Y,Mizutani Y,Lu J,Terachi T,Ogawa O.Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.Int J Oncol 2001; 19:19-24
  • 9Bleicher RJ,Cabot MC.Glucosylceramide synthase and apoptosis.Biochim Biophys Acta 2002; 1585:172-178
  • 10Reynolds CP,Maurer BJ,Kolesnick RN.Ceramide synthesis and metabolism as a target for cancer therapy.Cancer Lett 2004; 206:169-180

共引文献5

同被引文献8

  • 1吕伟,张超,郝嘉,刘伟,郝迎学,余佩武.shRNA沉默VEGF基因表达对大肠癌细胞生物学特性的影响[J].第三军医大学学报,2006,28(5):447-450. 被引量:5
  • 2Dann CT. New technology for an old favorite: lentiviral transgenesis and RNAi in rats [ J ]. Transgenic Res, 2007, 16(5) :571.
  • 3Sun P,Gao J,Liu YL,et al. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances Epirubicin sensitivity of breast cancer cells [ J ]. Mol Cell Biochem ,2008,308 ( 1/2 ) : 161.
  • 4Dykxhoorn DM,Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression[ J]. Nat Rev Mol Cell Biol, 2003, 4(6) :457.
  • 5March JC, Bentley WE. RNAi-based tuning of cell cycling in Drosophila S2 cells effects on recombinant protein yield [ J ]. Appl Microbiol Bioteehnol,2007,73 ( 5 ) : 1 128.
  • 6Canitrot Y, Cazaux C, Frechet M, et al. Over expression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs [ J ]. Proc Natl,Acad,Sci USA,1998, 95(21) :12 586.
  • 7Canitrot Y, Frechet M, Servant L, et al. Overpression of DNA polymerasebeta: a genomic instability enhancer process[J]. FASEB J,1999,13(9):1 107.
  • 8Schutze N. siRNA technology [ J ]. Mol Cell Endocrinol, 2004,213(2) :115.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部